Yulia Ivanova

Yulia Ivanova is a Principal Scientist at Pfizer, where they lead gene therapy downstream process development, focusing on maximizing recovery and optimizing chromatographic techniques. With a PhD in Biological Chemistry from Tufts University, Yulia possesses a decade of experience in industry and academia, specializing in Protein Biochemistry, purification, and biophysical characterization. Previously, they held roles at Abbott, Sigma-Aldrich, and Washington University School of Medicine, where they contributed to bioanalytical protein characterization and laboratory management. Yulia is recognized for their collaborative spirit, strong work ethics, and enthusiasm for scientific progress.